Overall, data show a strong link between Gal3 and obesity-induced insulin resistance in insulin-targeted hepatocytes, adipocytes, and myocytes, and thus the specific inhibition of Gal3 may offer a potential therapeutic strategy for restoring insulin sensitivity. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.